The Society for Maternal-Fetal Medicine (SMFM) and the Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) are deeply troubled by the inaccurate and misleading information regarding vaccines and autism recently posted to the Centers for Disease Control and Prevention (CDC) website. Continue Reading
News
Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
The SMFM Pregnancy Meeting™ returns in 2026 to Las Vegas with the energy, collaboration, and innovation that define our field. Each year, this meeting brings together clinicians, researchers, educators, and trainees united by a shared commitment to improving outcomes for pregnant people... Continue Reading
As we prepare for the 2026 Pregnancy Meeting™, I’m thrilled to share a preview of what promises to be one of our mostdynamic and inspiring gatherings yet. This year, we received a record-breaking 2,300+ abstract submissions, the highest in SMFM history! On behalf of the Program... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Brad Hart, MBA, MS, CPC, CPMA, COBGC 2026 Diagnosis Code Changes Each year on October 1, changes to the ICD-10-CM codes go into effect. For 2026, the changes are as follows: New Codes New... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce that Jerasimos Ballas, MD, MPH; Catherine S. Eppes, MD, MPH; Moeun Son, MD, MSCI; and Sarahn M. Wheeler, MD, MHSc, have been elected to the SMFM Board. Continue Reading
Prepregnancy counseling, assembling multidisciplinary care teams, and referring to centers with expertise are critical in managing pregnant patients with heart failure to optimize maternal and newborn health outcomes, according to new guidance issued by SMFM. Continue Reading
*This tip was originally published in April 2025 and has since been updated to reflect recent changes. The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Brad Hart, MBA, MS, CPC, CPMA, COBGC; Stephen Bacak, DO, FACOG; Steve Rad MD, FACOG, SMFM Coding Committee Chair, Trisha... Continue Reading
In response to today’s White House press conference announcement, The Society for Maternal-Fetal Medicine (SMFM) reiterates its recommendation advising both physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM), the national organization representing high-risk pregnancy experts, reiterates its recommendation that all pregnant and breastfeeding people receive the COVID-19 vaccine, regardless of trimester. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) and the Society of OB/GYN Hospitalists (SOGH) are pleased to announce a focused commitment to our partnership that prioritizes the advancement of hospital-based obstetric care across the United States. Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) continues to advise physicians and patients that acetaminophen is an appropriate medication to treat pain and fever during pregnancy. Continue Reading
By: Adam K. Lewkowitz, MD, MPHS, and Emily S. Miller, MD, MPH On July 21, 2025, the Food and Drug Administration (FDA) convened a roundtable panelist discussion on the use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medication, in pregnancy. The FDA... Continue Reading